Griffith launches human trials for a vaccine against Streptococcus A, the germ that causes rheumatic fever.
Griffith University’s Institute for Glycomics has developed a groundbreaking, combination vaccine that may finally beat Streptococcus A infections. Human trials are set to begin as early as next year.
Strep A (Streptococcus pyogenes) is a major cause of infection-related deaths, leading to over 500,000 fatalities annually. Developing countries, Indigenous populations, and vulnerable groups face the greatest risks. A potential vaccine, developed by Professor Michael Good's team at Griffith University, is undergoing human trials and shows promise in fighting multiple Strep A strains.
As Streptococcus A cases continue to be prevalent in Queensland and internationally, a new nasal vaccine could provide long-term protection from the deadly bacteria.
Griffith University researchers are on the brink of a technological breakthrough in vaccine development with a possible new vaccine modality.
A team of international scientists from Griffith University and the University of Alberta are about to start human clinical trials for a Strep A vaccine they hope will induce long-lasting immunity against the deadly pathogen which kills more than 500,000 people each year.
Griffith University Institute for Glycomics researchers are closer to the development of a new vaccine aimed at preventing the deadly Streptococcus A (Strep A), which kills more than 500,000 people globally per year.
Philanthropy has helped accelerate research into streptococcus leading scientists to exciting new discoveries in stroke and toxic shock prevention and treatments.
A new vaccine developed by Griffith University Institute for Glycomics researchers has the potential to treat and prevent toxic shock...
Griffith University will partner with a Chinese pharmaceutical for a new vaccine that has enormous potential to help millions. Clinical trials of the new, needle-free vaccine is targeted at Streptococcus A infection, the cause of strep throat and rheumatic heart disease and many other illnesses.
